Apricus Biosciences Receives FDA Clearance to Begin Clinical Trial of RayVa(TM) for Secondary Raynaud’s Phenomenon

[GlobeNewswire] – SAN DIEGO — Apricus Biosciences, Inc. , a pharmaceutical company focusing on the development and commercialization of novel therapeutics for men’s and women’s health, today announced that the U.S. Food … more

View todays social media effects on APRI

View the latest stocks trending across Twitter. Click to view dashboard

See who Apricus is hiring next, click here to view